Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04899362
Other study ID # SRIC-CA
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 20, 2021
Est. completion date July 30, 2021

Study information

Verified date May 2021
Source The First Hospital of Jilin University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the impact of serial remote ischemic conditioning on dynamic cerebral autoregulation and related hematology indexes in healthy adults.


Description:

Remote ischemic conditioning(RIC) is the phenomenon whereby brief cycles of ischemia and reperfusion, applied to a distant organ, provide protection to the target organ. Dynamic cerebral autoregulation(dCA), a mechanism to maintain the cerebral blood flow, has been proved to be critical for the occurrence,development and prognosis of ischemic neurovascular disease. In this study, we hypothesis that RIC provides neuro-protection by means of improving dCA.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date July 30, 2021
Est. primary completion date July 19, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - age from 18 to 50,both genders - willing to participate in follow-up visits Exclusion Criteria: - current or having a history of chronic physical diseases or mental diseases - suffering from infectious diseases in late one month - pregnant and lactating women# - smoking or drinking# - inability to cooperate sufficiently to complete the dCA examination

Study Design


Related Conditions & MeSH terms


Intervention

Device:
BB-RIC-D1/LAPUL Medical Devices Co, Ltd, China
The RIC consisted of 4 cycles of extremities ischemia (5-minute blood pressure cuff inflation to 200 mm Hg, followed by 5-minute cuff deflation). The tourniquets were applied to one side upper arm. This intervention was undertaken twice a day for 7 days.
Procedure:
Intravenous blood collection
Nurses will collect intravenous blood 3ml four times (at baseline and the first, seventh and eighth day of the study).The blood samples will be stored for laboratory test.The blood samples only use for the trial.
Device:
dCA measurement
Serial measurements of dCA were performed at 10 days, baseline, 1st, 2ed, 4th, 7th, 8th, 10th, 14th, 21th and 35th of the study.The continuous ABP was measured non-invasively using a servo-controlled plethysmograph (Finometer Pro, the Netherlands) at the middle finger. Two 2 MHz transcranial Doppler probe was used to measure continuous cerebral blood flow velocity (CBFV) simultaneously in the bilateral middle cerebral arteries at a depth of 45-60 mm Endtidal CO2 was monitored using a capnograph (MultiDop X2, DWL, Sipplingen, Germany). The probes were placed over temporal windows and fixed with a customized head frame. CBFV and continuous arterial blood pressure were recorded simultaneously from each subject in the supine position for 10 minutes. All data were recorded for further assessment and analysis.

Locations

Country Name City State
China First Hospital of Jilin University Changchun Jilin

Sponsors (1)

Lead Sponsor Collaborator
The First Hospital of Jilin University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Dynamic Cerebral Autoregulation Parameter: Phase Difference(PD) in Degree Dynamic cerebral autoregulation (dCA) is an important indicator of cerebrovascular function which related to the prognosis of cerebrovascular disease. DCA is usually calculated by transfer function analysis. Phase Difference (PD) is gengreated. Low PD at a low frequency band indicates impairment of autoregulation, as it suggests that cerebral blood flow velocity follows the changes in arterial blood pressure with a short delay. 36 days
Secondary Dynamic Cerebral Autoregulation Parameter: Gain in cm/s/mmHg High gain at the same frequency band is also considered an indicator of compromised autoregulation for passively transferring the amplitude of arterial blood pressure to cerebral blood flow velocity. 36 days
See also
  Status Clinical Trial Phase
Completed NCT05125861 - Dynamic Cerebral Autoregulation of Remote Ischemic Conditioning Combined With Intravenous Thrombolysis for Acute Ischemic Stroke N/A
Recruiting NCT04254432 - Safety and Feasibility of Remote Ischemic Conditioning on Prehypertension and Early-stage Hypertension Phase 1/Phase 2
Recruiting NCT05355883 - Remote Ischemic Conditioning, Bimanual Skill Learning, and Corticospinal Excitability Phase 2
Not yet recruiting NCT06141525 - Safety and Efficacy of Remote Ischemic Conditioning for Patients Taking Off-pump Coronary Artery Bypass Grafting (IMPROVE) N/A
Recruiting NCT05970653 - Effect of RIC on Cerebral Autoregulation in Patients Undergoing Cerebrovascular Stent Implantation N/A
Not yet recruiting NCT05860946 - Remote Ischemic Conditioning in Adult Moyamoya Disease Patients N/A
Completed NCT05598658 - Effect of Remote Ischemic Conditioning on Cerebral Hemodynamics in Patients After Intravenous Thrombolysis (RICCH-IVT) N/A